These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 25389909

  • 1. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Kersseboom S, Horn S, Visser WE, Chen J, Friesema EC, Vaurs-Barrière C, Peeters RP, Heuer H, Visser TJ.
    Mol Endocrinol; 2014 Dec; 28(12):1961-70. PubMed ID: 25389909
    [Abstract] [Full Text] [Related]

  • 2. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B, Gil-Ibañez P, Heuer H, Bernal J.
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [Abstract] [Full Text] [Related]

  • 3. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
    Mayerl S, Müller J, Bauer R, Richert S, Kassmann CM, Darras VM, Buder K, Boelen A, Visser TJ, Heuer H.
    J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
    [Abstract] [Full Text] [Related]

  • 4. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM, Kersseboom S, Yoon G, Visser TJ.
    PLoS One; 2015 May; 10(10):e0139343. PubMed ID: 26426690
    [Abstract] [Full Text] [Related]

  • 5. In Vitro Characterization of Human, Mouse, and Zebrafish MCT8 Orthologues.
    Groeneweg S, Kersseboom S, van den Berge A, Dolcetta-Capuzzo A, van Geest FS, van Heerebeek REA, Arjona FJ, Meima ME, Peeters RP, Visser WE, Visser TJ.
    Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
    [Abstract] [Full Text] [Related]

  • 6. 3,3',5-Triiodothyroacetic Acid Transporters.
    Chen Z, Yildiz S, Markova B, de Rooij LJ, Leeuwenburgh S, Hamers T, Peeters RP, Heuer H, Meima ME, Visser WE.
    Thyroid; 2024 Aug; 34(8):1027-1037. PubMed ID: 38836423
    [Abstract] [Full Text] [Related]

  • 7. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS, Namba N, Ohata Y, Fujiwara M, Nakano C, Takeyari S, Miyata K, Nakano Y, Yamamoto K, Nakayama H, Kitaoka T, Kubota T, Ozono K.
    Endocr J; 2019 Jan 28; 66(1):19-29. PubMed ID: 30369548
    [Abstract] [Full Text] [Related]

  • 8. Thyroid hormone transporters--functions and clinical implications.
    Bernal J, Guadaño-Ferraz A, Morte B.
    Nat Rev Endocrinol; 2015 Jul 28; 11(7):406-17. PubMed ID: 25942657
    [Abstract] [Full Text] [Related]

  • 9. TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice.
    Reinwald JR, Weber-Fahr W, Cosa-Linan A, Becker R, Sack M, Falfan-Melgoza C, Gass N, Braun U, Clemm von Hohenberg C, Chen J, Mayerl S, Muente TF, Heuer H, Sartorius A.
    Int J Mol Sci; 2022 Dec 08; 23(24):. PubMed ID: 36555189
    [Abstract] [Full Text] [Related]

  • 10. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
    Salas-Lucia F, Escamilla S, Bianco AC, Dumitrescu A, Refetoff S.
    JCI Insight; 2024 Feb 20; 9(7):. PubMed ID: 38376950
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.
    Groeneweg S, Peeters RP, Moran C, Stoupa A, Auriol F, Tonduti D, Dica A, Paone L, Rozenkova K, Malikova J, van der Walt A, de Coo IFM, McGowan A, Lyons G, Aarsen FK, Barca D, van Beynum IM, van der Knoop MM, Jansen J, Manshande M, Lunsing RJ, Nowak S, den Uil CA, Zillikens MC, Visser FE, Vrijmoeth P, de Wit MCY, Wolf NI, Zandstra A, Ambegaonkar G, Singh Y, de Rijke YB, Medici M, Bertini ES, Depoorter S, Lebl J, Cappa M, De Meirleir L, Krude H, Craiu D, Zibordi F, Oliver Petit I, Polak M, Chatterjee K, Visser TJ, Visser WE.
    Lancet Diabetes Endocrinol; 2019 Sep 20; 7(9):695-706. PubMed ID: 31377265
    [Abstract] [Full Text] [Related]

  • 12. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
    Liao XH, Avalos P, Shelest O, Ofan R, Shilo M, Bresee C, Likhite S, Vit JP, Heuer H, Kaspar B, Meyer K, Dumitrescu AM, Refetoff S, Svendsen CN, Vatine GD.
    Thyroid; 2022 Jul 20; 32(7):849-859. PubMed ID: 35350867
    [Abstract] [Full Text] [Related]

  • 13. Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression.
    Wilpert NM, Krueger M, Opitz R, Sebinger D, Paisdzior S, Mages B, Schulz A, Spranger J, Wirth EK, Stachelscheid H, Mergenthaler P, Vajkoczy P, Krude H, Kühnen P, Bechmann I, Biebermann H.
    Thyroid; 2020 Sep 20; 30(9):1366-1383. PubMed ID: 32143555
    [Abstract] [Full Text] [Related]

  • 14. Allan-Herndon-Dudley-Syndrome: Considerations about the Brain Phenotype with Implications for Treatment Strategies.
    Krude H, Biebermann H, Schuelke M, Müller TD, Tschöp M.
    Exp Clin Endocrinol Diabetes; 2020 Jun 20; 128(6-07):414-422. PubMed ID: 32242326
    [Abstract] [Full Text] [Related]

  • 15. Prenatal Treatment of Thyroid Hormone Cell Membrane Transport Defect Caused by MCT8 Gene Mutation.
    Refetoff S, Pappa T, Williams MK, Matheus MG, Liao XH, Hansen K, Nicol L, Pierce M, Blasco PA, Wiebers Jensen M, Bernal J, Weiss RE, Dumitrescu AM, LaFranchi S.
    Thyroid; 2021 May 20; 31(5):713-720. PubMed ID: 32746752
    [Abstract] [Full Text] [Related]

  • 16. Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain.
    De Angelis M, Maity-Kumar G, Schriever SC, Kozlova EV, Müller TD, Pfluger PT, Curras-Collazo MC, Schramm KW.
    J Pharm Biomed Anal; 2022 Nov 30; 221():115038. PubMed ID: 36152487
    [Abstract] [Full Text] [Related]

  • 17. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY, Kim MJ, Deliyanti D, Azari MF, Rossello F, Costin A, Ramm G, Stanley EG, Elefanty AG, Wilkinson-Berka JL, Petratos S.
    EBioMedicine; 2017 Nov 30; 25():122-135. PubMed ID: 29111262
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study.
    van Geest FS, Groeneweg S, van den Akker ELT, Bacos I, Barca D, van den Berg SAA, Bertini E, Brunner D, Brunetti-Pierri N, Cappa M, Cappuccio G, Chatterjee K, Chesover AD, Christian P, Coutant R, Craiu D, Crock P, Dewey C, Dica A, Dimitri P, Dubey R, Enderli A, Fairchild J, Gallichan J, Garibaldi LR, George B, Hackenberg A, Heinrich B, Huynh T, Kłosowska A, Lawson-Yuen A, Linder-Lucht M, Lyons G, Monti Lora F, Moran C, Müller KE, Paone L, Paul PG, Polak M, Porta F, Reinauer C, de Rijke YB, Seckold R, Menevşe TS, Simm P, Simon A, Spada M, Stoupa A, Szeifert L, Tonduti D, van Toor H, Turan S, Vanderniet J, de Waart M, van der Wal R, van der Walt A, van Wermeskerken AM, Wierzba J, Zibordi F, Zung A, Peeters RP, Visser WE.
    J Clin Endocrinol Metab; 2022 Feb 17; 107(3):e1136-e1147. PubMed ID: 34679181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development.
    Vancamp P, Darras VM.
    Gen Comp Endocrinol; 2018 Sep 01; 265():219-229. PubMed ID: 29183795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.